e-learning
resources
Paris 2018
Wednesday, 19.09.2018
Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relationship between blood eosinophil levels and severity of COPD
A. Ben Saad (Monastir, Tunisia), R. Khemakhem (Monastir, Tunisia), S. Cheikh Mhamed (Monastir, Tunisia), N. Fahem (Monastir, Tunisia), A. Migaou (Monastir, Tunisia), S. Joobeur (Monastir, Tunisia), N. Rouatbi (Monastir, Tunisia)
Source:
International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Session:
Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Session type:
Poster Discussion
Number:
5467
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Ben Saad (Monastir, Tunisia), R. Khemakhem (Monastir, Tunisia), S. Cheikh Mhamed (Monastir, Tunisia), N. Fahem (Monastir, Tunisia), A. Migaou (Monastir, Tunisia), S. Joobeur (Monastir, Tunisia), N. Rouatbi (Monastir, Tunisia). Relationship between blood eosinophil levels and severity of COPD. 5467
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Relationship between blood eosinophil count and bronchial epithelial gene expression in COPD versus Asthma
Source: International Congress 2018 – Eosinophils in airway disease
Year: 2018
Stability of sputum and blood eosinophil levels in COPD
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020
Relationship between the sevirity of the asthma disease in children with the concetration of Der.p.1 and the ECP in peripheral blood
Source: Eur Respir J 2003; 22: Suppl. 45, 288s
Year: 2003
Lack of seasonal variability of blood eosinophil counts in COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities.
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Relationship between CRTH2 mRNA expression in peripheral blood and IgE and eosinophil levels in adult patients with asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Comparison of relationship between eosinophil counts and the disease severity in ACO patients
Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation
Year: 2019
Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Associations between blood eosinophils and decline in lung function among adults with and without asthma
Source: Eur Respir J, 51 (4) 1702536; 10.1183/13993003.02536-2017
Year: 2018
Reproducibility of COPD blood eosinophil counts
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis
Source: International Congress 2015 – Epidemiological studies of asthma and allergy
Year: 2015
Variability in eosinophil levels at start of severe exacerbations of COPD
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
Associations of blood cytokines and eosinophils in severe asthma
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017
Elevated sputum complement factor H levels in COPD: Relationship with disease severity
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 279s
Year: 2003
Associations between blood and sputum eosinophils and clinical features of mild-to-moderate COPD
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Increased TNFα production in whole blood is associated with disease severity in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 497s
Year: 2002
Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept